After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Iterum Therapeutics Plc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Iterum Therapeutics Plc is $24.53M. A total of 0.52 million shares were traded on the day, compared to an average of 296.19K shares.
In the most recent transaction, Dunne Michael W. bought 25,000 shares of ITRM for 1.40 per share on Dec 22 ’23. After the transaction, the Director now owns 113,754 company shares. In a previous transaction on Dec 18 ’23, Dunne Michael W. bought 10,000 shares at 1.84 per share. ITRM shares that Director owns now total 88,754.
Among the insiders who bought shares, Dunne Michael W. acquired of 20,000 shares on Nov 22 ’23 at a per-share price of $2.03. This resulted in the Director holding 78,754 shares of ITRM after the transaction. In another insider transaction, Fishman Corey N. bought 10,000 shares at $1.59 per share on Nov 20 ’23. Company shares held by the Chief Executive Officer now total 54,449.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ITRM has a high of $2.50 and a low of $0.62.
As of this writing, ITRM has an earnings estimate of -$0.2 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.17 per share and a lower estimate of -$0.23. The company reported an EPS of -$0.3 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ITRM’s latest balance sheet shows that the firm has $81.38M in Cash & Short Term Investments as of fiscal 2021. There were $26.52M in debt and $12.94M in liabilities at the time. Its Book Value Per Share was -$0.66, while its Total Shareholder’s Equity was $50.23M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ITRM is Buy with a score of 5.00.
